Citadel Advisors’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $879K | Buy |
|
|||||
|
2025
Q2 | $372K | Sell |
|
|||||
|
2025
Q1 | $528K | Sell |
|
|||||
|
2024
Q4 | $908K | Sell |
|
|||||
|
2024
Q3 | $2.34M | Buy |
|
|||||
|
2024
Q2 | $448K | Sell |
|
|||||
|
2024
Q1 | $5.15M | Buy |
|
|||||
|
2023
Q4 | $4.83M | Sell |
|
|||||
|
2023
Q3 | $4.1M | Sell |
|
|||||
|
2023
Q2 | $5.28M | Buy |
|
|||||
|
2023
Q1 | $670K | Sell |
|
|||||
|
2022
Q4 | $855K | Buy |
|
|||||
|
2022
Q3 | $358K | Buy |
|
|||||
|
2022
Q2 | $223K | Sell |
|
|||||
|
2022
Q1 | $1.08M | Buy |
|
|||||
|
2021
Q4 | $1.32M | Sell |
|
|||||
|
2021
Q3 | $1.46M | Buy |
|
|||||
|
2021
Q2 | $336K | Sell |
|
|||||
|
2021
Q1 | $2.32M | Buy |
|
|||||
|
2020
Q4 | $351K | Buy |
|
|||||
|
2020
Q3 | $219K | Sell |
|
|||||
|
2020
Q2 | $2.46M | Sell |
|
|||||
|
2020
Q1 | $2.5M | Buy |
|
|||||
|
2019
Q4 | $153K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $25K | Sell |
|
|||||
|
2019
Q1 | $51K | Buy |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $574K | Buy |
|
|||||
|
2018
Q1 | $324K | Buy |
|
|||||
|
2017
Q4 | $146K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $52K | Buy |
|
|||||
|
2017
Q1 | $34K | Sell |
|
|||||
|
2016
Q4 | $93K | Buy |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.2M | Sell |
|
|||||
|
2015
Q3 | $4.6M | Buy |
|
|||||
|
2015
Q2 | $4.24M | Sell |
|
|||||
|
2015
Q1 | $6.29M | Buy |
|
|||||
|
2014
Q4 | $157K | Buy |
|
|||||
|
2014
Q3 | $68K | Buy |
|
|||||
|
2014
Q2 | $34K | Buy |
|